SPTSSA
Serine palmitoyltransferase small subunit A
Also known as: C14orf147, SPTSA_HUMAN, ssSPTa
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969W0
- Gene
- SPTSSA
- Ensembl
- ENSG00000165389
- Chromosome
- 14
- Canonical length
- 71 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
Serine palmitoyltransferase (SPT; EC 2.3.1.50) catalyzes the first committed and rate-limiting step in sphingolipid biosynthesis. SSSPTA is a small SPT subunit that stimulates SPT activity and confers acyl-CoA preference to the SPT catalytic heterodimer of SPTLC1 (MIM 605712) and either SPTLC2 (MIM 605713) or SPTLC3 (MIM 611120) (Han et al., 2009 [PubMed 19416851]).[supplied by OMIM, Nov 2010]
Canonical amino-acid sequenceUniProt
71 residues, UniProt reviewed canonical sequence.
>Q969W0|SPTSSA
1 MAGMALARAW KQMSWFYYQY LLVTALYMLE PWERTVFNSM LVSIVGMALY TGYVFMPQHI
61 MAILHYFEIV QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPTSSA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 67 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 67 nTPM
- liver: 44 nTPM
- breast: 37 nTPM
- colon: 36 nTPM
- rectum: 34 nTPM
- lung: 33 nTPM
Single-cell type
- tuft cells: 12 nCPM
- breast lactating cells: 7.5 nCPM
- epicardial cells: 2.3 nCPM
- alveolar cells type 2: 2.2 nCPM
- ocular epithelial cells: 1.6 nCPM
- enterocytes: 1.5 nCPM
Immune cell
- classical monocyte: 37 nTPM
- intermediate monocyte: 30 nTPM
- non-classical monocyte: 26 nTPM
- basophil: 22 nTPM
- total PBMC: 22 nTPM
- NK-cell: 21 nTPM
Brain region
- medulla oblongata: 26 nTPM
- hypothalamus: 21 nTPM
- white matter: 20 nTPM
- pons: 20 nTPM
- midbrain: 19 nTPM
- spinal cord: 19 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SPTSSA.
Disease | AllUniProt
Conditions SPTSSA is implicated in, by any mechanism.
- Spastic paraplegia 90A, autosomal dominant (SPG90A) MIM:620416
- Spastic paraplegia 90B, autosomal recessive (SPG90B) MIM:620417
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 16 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spastic paraplegia 90B, autosomal recessive
- Spastic paraplegia 90A, autosomal dominant
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.89
- gnomAD pLI
- 0.65
- gnomAD missense Z
- 0.23
- DepMap mean gene effect
- -0.38
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ceramide biosynthetic process
- intracellular protein localization
- sphingolipid biosynthetic process
- sphingosine biosynthetic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Small subunit of serine palmitoyltransferase-like
- Small subunit of serine palmitoyltransferase-like
- Serine palmitoyltransferase small subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SPTSSA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPTSSA as an antibody target. Whether an autoantibody or antibody against SPTSSA could matter depends on whether native SPTSSA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPTSSA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPTSSA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...